BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 22013060)

  • 1. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
    Sivachandran N; Cao JY; Frappier L
    J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.
    Sivachandran N; Wang X; Frappier L
    J Virol; 2012 Jun; 86(11):6146-58. PubMed ID: 22491455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
    Sides MD; Block GJ; Chadwick RW; Shan B; Flemington EK; Lasky JA
    Virol J; 2011 Oct; 8():461. PubMed ID: 21975125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr nuclear antigen 1 in gastric carcinoma cells is associated with enhanced tumorigenicity and reduced cisplatin sensitivity.
    Cheng TC; Hsieh SS; Hsu WL; Chen YF; Ho HH; Sheu LF
    Int J Oncol; 2010 Jan; 36(1):151-60. PubMed ID: 19956844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
    Westhoff Smith D; Sugden B
    Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
    Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
    Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBNA1.
    Frappier L
    Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections.
    Malik-Soni N; Frappier L
    J Virol; 2012 Jun; 86(12):6999-7002. PubMed ID: 22496234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
    Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
    Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
    Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
    Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.
    Cao JY; Mansouri S; Frappier L
    J Virol; 2012 Jan; 86(1):382-94. PubMed ID: 22013061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the Aurora kinase A and Epstein-Barr nuclear antigen 1 axis in Epstein Barr virus associated gastric cancer.
    Varshney N; Murmu S; Baral B; Kashyap D; Singh S; Kandpal M; Bhandari V; Chaurasia A; Kumar S; Jha HC
    Virology; 2023 Nov; 588():109901. PubMed ID: 37839162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
    Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
    PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.
    Soldan SS; Anderson EM; Frase DM; Zhang Y; Caruso LB; Wang Y; Deakyne JS; Gewurz BE; Tempera I; Lieberman PM; Messick TE
    Gastric Cancer; 2021 Sep; 24(5):1076-1088. PubMed ID: 33929613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.
    Ho TH; Sitz J; Shen Q; Leblanc-Lacroix A; Campos EI; Borozan I; Marcon E; Greenblatt J; Fradet-Turcotte A; Jin DY; Frappier L
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.